不安足症候群と下肢脂肪組織の厚さとの関連:新しい視点
Elif Sarica Darol1, Dilcan Kotan2
1Sakarya University, Training and Research Hospital, Neurology Clinic, Sakarya, Türkiye.
Arquivos de neuro-psiquiatria
|August 31, 2025
まとめ
下肢の皮下脂肪組織の厚さは,不安な足症候群 (RLS) の病理生理学に役割を果たす可能性があります. 体重指数とは関係なく,中部脂肪組織の厚さの減少がRLSと有意に関連していました.
科学分野:
- 神経科学
- 代謝障害
- 体組成分析
背景:
- 落ち着かない足症候群 (RLS) は,女性の性別と肥満を含む既知の危険因子を持つ神経疾患です.
- RLSと身体の組成,特に皮下脂肪組織の厚さ (ATT) の関係は,特にボディマス指数 (BMI) から独立して未熟のままです.
研究 の 目的:
- 下肢の皮下脂肪組織の厚さ (ATT) と不安な足症候群 (RLS) の間の相関を調査する.
- BMIとは無関係に,ATTがRLSと関連しているかどうかを判断する.
主な方法:
- 212人のRLS患者と92人の対照群を対象としたケース・コントロール研究.
- 脂肪組織の厚さ (ATT) は,中盤と膝の領域でカリパーを使用して測定されました.
- 統計的分析には,ATTとRLSの関連性を評価するための複数のロジスティック回帰が含まれ,他の要因を制御しました.
主要な成果:
- RLS患者では,対照群と比較して,ミッドカルフATが有意に低かった (p < 0. 0005).
- 中部ATTの減少は,RLSの増加の確率 (OR=1. 107単位減少) と関連付けられました.
- 年齢,フェリチン,ビタミンDレベルなどの要因も独立してRLSの確率と関連していました.
結論:
- 下肢の皮下脂肪組織の厚さは,特に中腰部では,RLSの病理生理学における重要な要因である可能性があります.
- この関連性は,全体のBMIから独立しているようで,脂肪組織が局所的な役割を果たしていることを示唆している.
- 足のATTとRLSの関係にあるメカニズムを明らかにするためにさらなる研究が必要です.
関連する概念動画
01:27Restless Leg Syndrome and Night Terrors
249
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
249
01:29Cholesterol: Significance and Regulation
669
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
669
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
34
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
34
01:02Hypodermis
5.3K
The hypodermis (the subcutaneous layer or superficial fascia) is present directly below the dermis. It connects the skin to the underlying fascia (fibrous tissue) of the bones and muscles. It is not strictly a part of the skin, although the border between the hypodermis and dermis can be difficult to distinguish. The hypodermis consists of well-vascularized, loose, areolar connective tissue and adipose tissue, which functions as a mode of fat storage and provides insulation and cushioning for...
5.3K
01:24Obesity
609
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
609
01:27Assessment of the Cardiovascular System III: Palpation
492
Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
492